BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36482218)

  • 1. The diagnostic and prognostic role of combined [
    Albano D; Dondi F; Bauckneht M; Albertelli M; Durmo R; Filice A; Versari A; Morbelli S; Berruti A; Bertagna F
    Eur Radiol; 2023 Jun; 33(6):4167-4177. PubMed ID: 36482218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utility of 18F-FDG and 68Ga-DOTA-Peptide PET/CT in the evaluation of primary pulmonary carcinoid: A systematic review and meta-analysis.
    Jiang Y; Hou G; Cheng W
    Medicine (Baltimore); 2019 Mar; 98(10):e14769. PubMed ID: 30855482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter comparison of 18F-FDG and 68Ga-DOTA-peptide PET/CT for pulmonary carcinoid.
    Lococo F; Perotti G; Cardillo G; De Waure C; Filice A; Graziano P; Rossi G; Sgarbi G; Stefanelli A; Giordano A; Granone P; Rindi G; Versari A; Rufini V
    Clin Nucl Med; 2015 Mar; 40(3):e183-9. PubMed ID: 25608152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theranostic implications of molecular imaging phenotype of well-differentiated pulmonary carcinoid based on
    Zidan L; Iravani A; Kong G; Akhurst T; Michael M; Hicks RJ
    Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):204-216. PubMed ID: 32572559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of [
    Deleu AL; Laenen A; Decaluwé H; Weynand B; Dooms C; De Wever W; Jentjens S; Goffin K; Vansteenkiste J; Van Laere K; De Leyn P; Nackaerts K; Deroose CM
    EJNMMI Res; 2022 May; 12(1):28. PubMed ID: 35524900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of 68Ga-DOTATOC PET/CT in initial evaluation of patients with suspected bronchopulmonary carcinoid.
    Venkitaraman B; Karunanithi S; Kumar A; Khilnani GC; Kumar R
    Eur J Nucl Med Mol Imaging; 2014 May; 41(5):856-64. PubMed ID: 24435773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The added value of [
    Liu Q; Shi S; Liu S; Xu X; Hu S; Zhang J; Wang C; Yu X; Song S
    Eur Radiol; 2023 Jul; 33(7):5007-5016. PubMed ID: 36809431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does 68Ga-DOTA-NOC-PET/CT impact staging and therapeutic decision making in pulmonary carcinoid tumors?
    Purandare NC; Puranik A; Agrawal A; Shah S; Kumar R; Jiwnani S; Karimundackal G; Pramesh CS; Rangarajan V
    Nucl Med Commun; 2020 Oct; 41(10):1040-1046. PubMed ID: 32732596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the role of [18F]FDG-PET/CT and [68Ga]DOTATOC-PET/CT in differentiating typical and atypical pulmonary carcinoids.
    Jindal T; Kumar A; Venkitaraman B; Meena M; Kumar R; Malhotra A; Dutta R
    Cancer Imaging; 2011 Jun; 11(1):70-5. PubMed ID: 21697027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of (18F)FDG PET/CT and (68Ga)DOTATATE PET/CT imaging methods in terms of detection of histological subtype and related SUVmax values in patients with pulmonary carcinoid tumors.
    Komek H; Can C; Urakçi Z; Kepenek F
    Nucl Med Commun; 2019 May; 40(5):517-524. PubMed ID: 30694875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performances of 68Ga-DOTATOC versus 18Fluorodeoxyglucose positron emission tomography in pulmonary carcinoid tumours and interrelationship with histological features.
    Lococo F; Rapicetta C; Mengoli MC; Filice A; Paci M; Di Stefano T; Coruzzi C; Versari A
    Interact Cardiovasc Thorac Surg; 2019 Jun; 28(6):957-960. PubMed ID: 30753507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [
    Lin R; Lin Z; Chen Z; Zheng S; Zhang J; Zang J; Miao W
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2960-2971. PubMed ID: 35462566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential utility of [
    Lan L; Liu H; Wang Y; Deng J; Peng D; Feng Y; Wang L; Chen Y; Qiu L
    Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):963-979. PubMed ID: 34410435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential diagnostic value of
    Zhao J; Wang H
    Acad Radiol; 2022 Feb; 29 Suppl 2():S41-S46. PubMed ID: 33183953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional imaging in differentiating bronchial masses: an initial experience with a combination of (18)F-FDG PET-CT scan and (68)Ga DOTA-TOC PET-CT scan.
    Kumar A; Jindal T; Dutta R; Kumar R
    Ann Nucl Med; 2009 Oct; 23(8):745-51. PubMed ID: 19784877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of [
    Chen H; Pang Y; Wu J; Zhao L; Hao B; Wu J; Wei J; Wu S; Zhao L; Luo Z; Lin X; Xie C; Sun L; Lin Q; Wu H
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1820-1832. PubMed ID: 32222810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors.
    Kayani I; Conry BG; Groves AM; Win T; Dickson J; Caplin M; Bomanji JB
    J Nucl Med; 2009 Dec; 50(12):1927-32. PubMed ID: 19910422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher accuracy of [
    Zhou X; Wang S; Xu X; Meng X; Zhang H; Zhang A; Song Y; Zhu H; Yang Z; Li N
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2983-2993. PubMed ID: 35543731
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Parihar AS; Mittal BR; Kumar R; Shukla J; Bhattacharya A
    Thyroid; 2020 Apr; 30(4):557-567. PubMed ID: 31870227
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.